Combined single-cell profiling of chromatin-transcriptome and splicing across brain cell types, regions and disease state.

TitleCombined single-cell profiling of chromatin-transcriptome and splicing across brain cell types, regions and disease state.
Publication TypeJournal Article
Year of Publication2025
AuthorsHu W, Foord C, Hsu J, Fan L, Corley MJ, Lanjewar SN, Xu S, Belchikov N, He Y, Pang APS, Bhatia TN, Jarroux J, Joglekar A, Milner TA, Ndhlovu LC, Zhang J, Butelman E, Sloan SA, M Y Lee V, Gan L, Tilgner HU
JournalNat Biotechnol
Date Published2025 Jul 22
ISSN1546-1696
Abstract

Measuring splicing and chromatin accessibility simultaneously in frozen tissues remains challenging. Here we combined single-cell isoform RNA sequencing and assay for transposase accessible chromatin (ScISOr-ATAC) to interrogate the correlation between these modalities in single cells in human and rhesus macaque frozen cortical tissue samples. Applying a previous definition of four 'cell states' in which the transcriptome and chromatin accessibility are coupled or decoupled for each gene, we demonstrate that splicing patterns in one cell state can differ from those of another state within the same cell type. We also use ScISOr-ATAC to measure the correlation of chromatin and splicing across brain cell types, cortical regions and species (macaque and human) and in Alzheimer's disease. In macaques, some excitatory neuron subtypes show brain-region-specific splicing and chromatin accessibility. In human and macaque prefrontal cortex, strong evolutionary divergence in one molecular modality does not necessarily imply strong divergence in another modality. Finally, in Alzheimer's disease, oligodendrocytes show high dysregulation in both chromatin and splicing.

DOI10.1038/s41587-025-02734-5
Alternate JournalNat Biotechnol
PubMed ID40696189
PubMed Central ID7669735
Grant ListR01 GM135247 / GM / NIGMS NIH HHS / United States
U01 DA053625-01 / / U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) /
U01 DA053625 / DA / NIDA NIH HHS / United States
2T32DA039080 / / U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (NIDA) /
T32 DA039080 / DA / NIDA NIH HHS / United States
RF1 MH121267 / MH / NIMH NIH HHS / United States
R01 MH125956 / MH / NIMH NIH HHS / United States
R01 NS123562 / NS / NINDS NIH HHS / United States
1RF1 MH121267-01 / / U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (NIMH) /
GRFP # 2139291 / / National Science Foundation (NSF) /
U01 DA058527 / DA / NIDA NIH HHS / United States
R01 MH125737 / MH / NIMH NIH HHS / United States
R01 MH134391 / MH / NIMH NIH HHS / United States
R01 MH130197 / MH / NIMH NIH HHS / United States
1R01 GM135247-01 / / U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (NIGMS) /